Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus - a Feasible Clinical Trial Protocol

NCT05631561 is registered in ClinicalTrials.gov with Shanghai Golden Leaf MedTec Co. Ltd as lead sponsor.

NCT NCT05631561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus - a Feasible Clinical Trial Protocol
Lead sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
December 27, 2022
Completion date
February 28, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)